Anders Asberg
Columnista Experta de SIIC


Professor, Department of Pharmaceutical Bioscience, School of Pharmacy, University of Oslo, Oslo, Noruega
INTERACCIONES BILATERALES ENTRE CICLOSPORINA A Y TRATAMIENTOS HIPOLIPEMIANTES
Columnista Experta de SIIC Anders Asberg en colaboración con


Fecha de aprobación: 13 de julio, 2005
Primera edición en siicsalud: 20 de febrero, 2006
Sección Artículos originales, subsección Expertos de Iberoamérica,
página /des/expertocompleto.php/75078  
Especialidad principal: Especialidad principalFarmacología
Especialidad principalTrasplantes

Especialidades relacionadas:
Cardiología,Diagnóstico por Laboratorio,Medicina Farmacéutica,Inmunología,Medicina Interna,

  • Hjelmesaet J, Åsberg A, Hartmann A, Jenssen T. New-onset diabetes mellitus after renal transplantation: diagnosis and treatment, Int Diabetes Monitor 5(5):15-21

  • Lemahieu WPD, Hermann M, Åsberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD. Combined therapy with atorvastatin and calcineurin inhibitors: No interaction with tacrolimus, Am J Transplant 5:2236-2243, 2005

  • Hermann M, Åsberg A, Christensen H, Reubsaet JLE, Holdaas H, Hartmann A. Atorvastatin does not affect pharmacokinetics of cyclosporine in renal transplant recipients, Eur J Clin Pharmacol 61:59-62, 2005

  • Voytovich MH, Simonsen C, Jenssen T, Åsberg A, Midtvedt K, Hjelmesaeth J, Hartmann A. Short term treatment with rosiglitazone improves glucose disposal rate and endothelial function in renal transplant recipients with glucose intolerance, Nephrol Dial Transplant 20:413-418, 2005

  • Hjelmesaeth J, Åsberg A, Müller F, Jenssen T, Hartmann A. New-onset posttransplantation diabetes mellitus: Insulin resistance or insulinopenia Impact of immunosuppressive drugs, hepatitis C virus and cytomegalovirus infection, Current Diabetes Reviews 1(1):1-10, 2005

  • Hermann M, Åsberg A, Christensen H, Holdaas H, Hartmann A, Reubsaet JLE. Substantially elevated levels of atorvastatin and metabolites in cyclosporine A treated renal transplant recipients, Clin Pharm Ther 76(76):388-391, 2004

  • Åsberg, A and Holdaas H Fluvastatin and fluvastatin extended release: a clinical and safety profile, Expert Rev Cardiovasc Ther 2(2):641-652, 2004

  • Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Åsberg A, Degré M, Fauchald P, Rollag H. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomised, comparative study, Nephrol Dial Transplant 18(18):1899-1908, 2003


  • Anders Asberg

    ua40317

    Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008